Single-Oral-Dose Azithromycin Prophylaxis against Experimental Streptococcal or Staphylococcal Aortic Valve Endocarditis

Azithromycin and ampicillin protected 94 and 72% of animals challenged with Streptococcus oralis, respectively (P = 0.177), while azithromycin and vancomycin protected 59 and 94% of the methicillin-resistant Staphylococcus aureus (MRSA)-challenged animals, respectively (P = 0.018). Azithromycin is e...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tsitsika, Artemis, Pefanis, Angelos, Perdikaris, George S., Donta, Ismini, Karayiannakos, Panayiotis, Giamarellou, Helen
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2000
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC89953/
https://ncbi.nlm.nih.gov/pubmed/10817749
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires